Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial

Professor Toby Richards, our Clinical Lead for Vascular Surgery, and his colleagues are testing the benefits and risks of IV iron administration in anemic patients awaiting cardiac surgery. This is important research, given that 20-30% of patients awaiting cardiac surgery are anemic, and that this increases the likelihood of requiring a red cell transfusion and is associated with further complications, intensive care, and hospital stay following surgery.

Iron deficiency is the primary cause of anemia and so administering it preoperatively may tackle the disease, and improve patient outcomes following cardiac surgery.

Read the full report here

Other news

28th May 2022

Retinal Detachment

UK Biobank project that our Ophthalmology Clinical Lead, Danny Mitry is involved with, focuses on Rhegmatogenous retinal detachment (RRD),…
25th April 2022

Crowdsourcing

Mr Danny Mitry, our Ophthalmology Clinical Lead, is working on some fascinating and important projects with the UK Biobank.
31st March 2022

Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients

Professor Toby Richards, our Clinical Lead for Vascular Surgery, and his colleagues have been investigating the functional recovery of…